Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology | Neurology | Genetic Disease | Family Medicine
Disease Category: Bipolar Disorder
Location: United States, IL
Preventing the Recurrence of Depression in Bipolar Disorder
This study compares combination treatment with a mood stabilizer plus an antidepressant to treatment with the mood stabilizer alone and to gather information about the safety, tolerability and frequency of mood changes during continuation treatment. The purpose is to collect information about whether the combination treatment results in fewer returns of depressive symptoms compared to treatment with the mood stabilizer alone. Both study drugs are FDA-approved. Study participation can last up to 62 weeks.
CW ID: 164482
Date Last Changed:
July 24, 2013
Linda SkaggsRush University Medical Center - Treatment Research Center1700 W. Van Buren Street, 5th FloorChicago, IL 60612Phone: 312-980-6356Fax: 312-942-2177
Rush University Medical Center - Treatment Research Center
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
We value your privacy and your information will only be used by the research center to contact
you regarding this study.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2015 CenterWatch.